Due to the fast transmission speed and severe health damage, COVID-19 has attracted global attention. Early diagnosis and isolation are effective and imperative strategies for epidemic prevention and control. Most diagnostic methods for the COVID-19 is based on nucleic acid testing (NAT), which is expensive and time-consuming. To build an efficient and valid alternative of NAT, this article investigates the feasibility of employing computed tomography images of lungs as the diagnostic signals. Unlike normal lungs, parts of the lungs infected with the COVID-19 developed lesions, ground-glass opacity, and bronchiectasis became apparent. Through a public dataset, in this article, we propose an advanced residual learning diagnosis detection (RLDD) scheme for the COVID-19 technique, which is designed to distinguish positive COVID-19 cases from heterogeneous lung images. Besides the advantage of high diagnosis effectiveness, the designed residual-based COVID-19 detection network can efficiently extract the lung features through small COVID-19 samples, which removes the pretraining requirement on other medical datasets. In the test set, we achieve an accuracy of 91.33%, a precision of 91.30%, and a recall of 90%. For the batch of 150 samples, the assessment time is only 4.7 s. Therefore, RLDD can be integrated into the application programming interface and embedded into the medical instrument to improve the detection efficiency of COVID-19.
Keywords: COVID-19 diagnosis; Computed tomography (CT) image analysis; convolutional neural network (CNN); industrial Internet of Things (IIoT); residual learning diagnosis detection (RLDD).